German Govt To Rescue East Funds?
Germany's coalition government is expected to provide the eastern Germanhealth funds with bridging or bank credits to rescue them from "virtual collapse." However, the collapse is at present only suspected and based on estimates of fund deficits.
Bonn government sources said the plan would be shelved if the final third-quarter 1997 figures showed that the finances of the eastern German funds were not in a state of high tension.
The Health Ministry has declined to comment on the situation, and will neither confirm nor deny the existence of a rescue project. Speaking in Bonn, Green Party spokeswoman Monika Knoche attacked the plan, claiming that it was illegal, and merely a debt-lifting program to save Health Minister Horst Seehofer from the "fiasco" of unwanted hikes in fund contribution levels.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze